Featured News

The Celiac Disease Foundation is proud to announce that Robert Anderson, MB, ChB, PhD, has joined the Foundation as its Principal Science & Innovation Advisor. In his new role, Dr. Anderson will draw on his extensive background to provide scientific expertise and guidance to the organization and its stakeholders.  

The SynCeD Study is looking for adult volunteers with celiac disease to join a phase 2a clinical trial. Your participation could make a difference. 

The Cribsiders Podcast on pediatric medicine recently released an episode with a special guest, Dr. Dale Lee from Seattle Children's Hospital, about the diagnosis and management of celiac disease.

Looking for something fun to do with your friends and family, no matter where they are across the world? Learn more about the 2023 Turkey Trot 5k and how joining or creating a team can expand your fundraising and accelerate celiac disease research for treatment and a cure. 

The Celiac Disease Foundation, a trusted partner in optimizing patient recruitment and retention, announces the launch of its iRecruitCeliac platform, which brings together solutions to accelerate enrollment in clinical trials for celiac disease and comorbid conditions.

2023 promises to be a year full of robust research, advocacy, and education efforts on behalf of our patient community.

The Celiac Disease Foundation is pleased to announce it will provide patient recruitment and eligibility screening for Anokion’s phase 1b/2 clinical trial for KAN-101.

Comments submitted to U.S. Preventive Services Task Force on Draft Research Plan: Preventive Services for Food Insecurity.

The Senate Appropriations Committee has released their FY2021 funding recommendations, which includes report language directing NIH to support celiac disease research.

Patients Who Have Participated In a Celiac Disease Clinical Trial Needed for 2021 Patient Education & Advocacy Summit.